ENTASIS THERAPEUTICS HLDGS I's ticker is ETTX and the CUSIP is 293614103. A total of 20 filers reported holding ENTASIS THERAPEUTICS HLDGS I in Q3 2018. The put-call ratio across all filers is - and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2020 | $122,000 | -52.5% | 49,478 | -60.7% | 0.00% | – |
| Q3 2020 | $257,000 | +40.4% | 125,848 | +342.8% | 0.00% | – |
| Q2 2019 | $183,000 | -13.3% | 28,419 | -9.1% | 0.00% | – |
| Q1 2019 | $211,000 | +51.8% | 31,250 | -8.5% | 0.00% | – |
| Q4 2018 | $139,000 | -83.9% | 34,143 | -57.0% | 0.00% | -100.0% |
| Q3 2018 | $864,000 | – | 79,437 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Pivotal bioVenture Partners Investment Advisor LLC | 1,180,178 | $2,915,000 | 0.96% |
| Anson Funds Management LP | 92,626 | $229,000 | 0.05% |
| Virtu Financial LLC | 146,128 | $361,000 | 0.04% |
| Eventide Asset Management | 879,541 | $2,064,000 | 0.03% |
| TPG Group Holdings (SBS) Advisors, Inc. | 1,020,748 | $2,521,000 | 0.03% |
| OCCUDO QUANTITATIVE STRATEGIES LP | 14,442 | $36,000 | 0.01% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 120,000 | $296,000 | 0.01% |
| Granahan Investment Management | 85,654 | $212,000 | 0.01% |
| Jaffetilchin Investment Partners, LLC | 11,000 | $27,000 | 0.00% |
| Renaissance Technologies | 506,389 | $1,251,000 | 0.00% |